Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
688336
株式のランク
#3772
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
株価
$4.87
時価総額
$4.36B
変化（1日）
-5.47%
変化（1年）
-15.62%
国
CN
取引 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
カテゴリー
Healthcare
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd（688336）の配当利回りの履歴
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd（銘柄コード: 688336）の配当利回り（TTM）は2024-12-31時点で0.39%です。
過去5年間の平均配当利回り: 0.14%
過去5年間の平均配当利回り: 0.14%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd（688336）の2006から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 1.49% | 396.67% |
| 2025 | 0.30% | -23.08% |
| 2024 | 0.39% | 3,800.00% |
| 2023 | 0.01% | -50.00% |
| 2022 | 0.02% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | -100.00% |
| 2019 | 2.48% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | -100.00% |
| 2012 | 0.04% | 0.00% |
| 2011 | 0.00% | -100.00% |
| 2010 | 0.01% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.07% |
AU
|
|
| 0.56% |
BE
|
|
| 0.00% |
NL
|
